Uveal melanoma clinical trial doubles five-year survival rate
University of Iowa Health Care has developed a strong apparatus for researching and treating a rare and highly fatal cancer called uveal melanoma. One of…
Mohammed Milhem
-
-
Novel combination therapy for advanced melanoma points to future directions
Oncology research at its best drives new treatment options with life-saving potential. And, according to Mohammed Milhem, MBBS, Melanoma Program Director at UI’s Holden Comprehensive…
-
Eight Internal Medicine faculty honored during 2024 Celebration of Excellence
In recognition of its tradition of exemplary scholarly activity, the Roy J. and Lucille A. Carver College of Medicine (CCOM) held its annual Celebration of…
-
Milhem named HOBMT Division Director
The Department of Internal Medicine is pleased to announce that Mohammed Milhem, MBBS, will become the next Director of the Division of Hematology, Oncology, and…
-
Clinical trials in cancer at Iowa barely lose a step
Last week, the American Society of Clinical Oncology (ASCO) released a special report titled “A Guide to Cancer Care Delivery During the COVID-19 Pandemic.” It…
-
Iowa results part of NEJM publication
A recent issue of the New England Journal of Medicine features the results of a multi-site clinical trial in which Dr. Mo Milhem and the…
-
HOBMT Leadership Change
I am pleased to announce that we have implemented a new leadership structure for the Division of Hematology, Oncology, and Blood & Marrow Transplantation (HOBMT)….
-
Milhem Receives Humanism in Medicine Award
Mohammed Milhem, Clinical Professor in Hematology, Oncology, and Blood & Marrow Transplantation, has been awarded the Leonard Tow Humanism in Medicine Award from the Arnold…
-
By trusting in clinical trials, cancer patients spread the benefits of treatment innovations
by Tony Craine, Health at Iowa In spring 2015, Trent Phillips of Jesup, Iowa, felt a nagging pain in the back of his left leg…
